Josep Vilaseca

579 total citations · 2 hit papers
24 papers, 276 citations indexed

About

Josep Vilaseca is a scholar working on Pulmonary and Respiratory Medicine, Economics and Econometrics and General Health Professions. According to data from OpenAlex, Josep Vilaseca has authored 24 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Economics and Econometrics and 4 papers in General Health Professions. Recurrent topics in Josep Vilaseca's work include Health Systems, Economic Evaluations, Quality of Life (4 papers), Primary Care and Health Outcomes (3 papers) and Prostate Cancer Diagnosis and Treatment (3 papers). Josep Vilaseca is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (4 papers), Primary Care and Health Outcomes (3 papers) and Prostate Cancer Diagnosis and Treatment (3 papers). Josep Vilaseca collaborates with scholars based in Spain, United Kingdom and Netherlands. Josep Vilaseca's co-authors include Thomas Frese, Mehmet Ungan, Shlomo Vinker, Adam Windak, Eva Hummers, Richard Hobbs, David Herrera, Filippo Graziani, Lior Shapira and Ana Molina and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Environmental Research and Public Health and Journal Of Clinical Periodontology.

In The Last Decade

Josep Vilaseca

20 papers receiving 268 citations

Hit Papers

Association between periodontal diseases and cardiovascul... 2023 2026 2024 2025 2023 2024 40 80 120

Peers

Josep Vilaseca
Josep Vilaseca
Citations per year, relative to Josep Vilaseca Josep Vilaseca (= 1×) peers Danchen Qin

Countries citing papers authored by Josep Vilaseca

Since Specialization
Citations

This map shows the geographic impact of Josep Vilaseca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josep Vilaseca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josep Vilaseca more than expected).

Fields of papers citing papers by Josep Vilaseca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josep Vilaseca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josep Vilaseca. The network helps show where Josep Vilaseca may publish in the future.

Co-authorship network of co-authors of Josep Vilaseca

This figure shows the co-authorship network connecting the top 25 collaborators of Josep Vilaseca. A scholar is included among the top collaborators of Josep Vilaseca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josep Vilaseca. Josep Vilaseca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Singh, Deependra, André Lopes Carvalho, Josep Vilaseca, et al.. (2025). Monitoring of prostate cancer screening in the European Union: development of key performance indicators through the PRAISE-U project. EClinicalMedicine. 80. 103022–103022. 3 indexed citations
2.
Singh, Deependra, Valeria Panebianco, Josep Vilaseca, et al.. (2025). MRI capacity assessment for prostate cancer screening in five sites of Europe. European Journal of Radiology. 190. 112235–112235. 1 indexed citations
3.
4.
Poppel, Hendrik Van, Arnulf Stenzl, Josep Vilaseca, et al.. (2024). PSA testing in primary care: is it time to change our practice?. BMC Primary Care. 25(1). 436–436. 3 indexed citations
5.
Herrera, David, Mariano Sanz, Lior Shapira, et al.. (2024). Periodontal diseases and cardiovascular diseases, diabetes, and respiratory diseases: Summary of the consensus report by the European Federation of Periodontology and WONCA Europe. European Journal of General Practice. 30(1). 2320120–2320120. 34 indexed citations breakdown →
6.
Herrera, David, Mariano Sanz, Lior Shapira, et al.. (2023). Association between periodontal diseases and cardiovascular diseases, diabetes and respiratory diseases: Consensus report of the Joint Workshop by the European Federation of Periodontology (EFP) and the European arm of the World Organization of Family Doctors (WONCA Europe). Journal Of Clinical Periodontology. 50(6). 819–841. 124 indexed citations breakdown →
7.
Flier, Wiesje M. van der, Andreas U. Monsch, Marwan N. Sabbagh, et al.. (2023). Blood‐based biomarkers in Alzheimer's disease: Future directions for implementation. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 15(4). e12508–e12508. 10 indexed citations
8.
Ahmed, Wasim, Josep Vidal‐Alaball, & Josep Vilaseca. (2023). Analyzing Discussions Around Rural Health on Twitter During the COVID-19 Pandemic: Social Network Analysis of Twitter Data. SHILAP Revista de lepidopterología. 3. e39209–e39209. 2 indexed citations
9.
Vilaseca, Josep. (2023). El mundo al revés. 42–44.
11.
Orozco‐Beltrán, Domingo, Juan Francisco Merino-Torres, Antonio Pérez, et al.. (2022). Diabetes Does Not Increase the Risk of Hospitalization Due to COVID-19 in Patients Aged 50 Years or Older in Primary Care—APHOSDIAB—COVID-19 Multicenter Study. Journal of Clinical Medicine. 11(8). 2092–2092. 2 indexed citations
12.
Carboni, Margherita, Wiesje M. van der Flier, Andreas U. Monsch, et al.. (2022). Roadmap to implementation of a fully automated blood‐based biomarker test to facilitate diagnosis and treatment in early Alzheimer’s disease. Alzheimer s & Dementia. 18(S6). 1 indexed citations
13.
Marín-Gomez, Francesc X, Jacobo Mendioroz, Miguel Ángel Mayer, et al.. (2022). Comparing the Clinical Characteristics and Mortality of Residential and Non-Residential Older People with COVID-19: Retrospective Observational Study. International Journal of Environmental Research and Public Health. 19(1). 483–483. 9 indexed citations
14.
Farrús, Mireia, et al.. (2021). Speech-Based Support System to Supervise Chronic Obstructive Pulmonary Disease Patient Status. Applied Sciences. 11(17). 7999–7999. 10 indexed citations
15.
Windak, Adam, Thomas Frese, Eva Hummers, et al.. (2020). Academic general practice/family medicine in times of COVID-19 – Perspective of WONCA Europe. European Journal of General Practice. 26(1). 182–188. 27 indexed citations
16.
Rochfort, Andrée, et al.. (2020). DIAGNOSING DEATH AND RESURRECTING THE MYTH OR REALITY OF CATALEPSY. 14(SUPPLEMENT 1). 1–8.
17.
Vilaseca, Josep & Mireia Sans-Corrales. (2018). Alma Ata 40th anniversary: Milestones of primary health care. Medicina Clínica (English Edition). 151(11). 441–443. 1 indexed citations
18.
Vilaseca, Josep, et al.. (2012). Validación de la versión en español del cuestionario PCAS para evaluar la atención primaria de salud. Revista Panamericana de Salud Pública. 31(1). 32–39. 3 indexed citations
19.
Sicras‐Mainar, Antoni, et al.. (2009). The relationship between effectiveness and costs measured by a risk-adjusted case-mix system: multicentre study of Catalonian population data bases. BMC Public Health. 9(1). 202–202. 5 indexed citations
20.
Vilaseca, Josep. (1996). Baptisme i medicina en un text del segle XIX. 25(25). 267–280.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026